Skip to main content
Darell Bigner, MD, Neurology, Durham, NC

Darell Doty Bigner MD

Neurology•Durham, NC

Professor, Pathology, Duke University School of Medicine

Join to View Full Profile

  • Duke Medical Ctr# 3156Durham, NC 27710

  • Phone+1 919-684-5018

  • Fax+1 919-684-6458

Dr. Bigner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Bigner's Full ProfileAlready have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Surgery, 1970 - 1970
  • Duke University Hospital
    Duke University HospitalResidency, Neurological Surgery, 1966 - 1968
  • Duke University Hospital
    Duke University HospitalInternship, Transitional Year, 1965 - 1966
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1965

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1966 - 2025
  • GA State Medical License
    GA State Medical License 1965 - 1975

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Recurrent Glioblastoma Treated with Recombinant Poliovirus  
    Darell Bigner, MD, The New England Journal of Medicine
  • The Genomic Landscape of TERT Promoter Wildtype-IDH Wildtype Glioblastoma  
    Daniel B. Loriaux, Darel D. Bigner, Fausto J. Rodriguez, Hai Yan, Bil H. Diplas, Henry S. Friedman, Roger E. McLendon, Nature

Press Mentions

  • New Brain Tumor Drug Hits Market 16 Years After Duke Neurosurgeon's Discovery: ' Excited'
    New Brain Tumor Drug Hits Market 16 Years After Duke Neurosurgeon's Discovery: ' Excited'August 27th, 2024
  • FDA Gives Patients Hope After Approving Brain Cancer Drug with Duke Ties
    FDA Gives Patients Hope After Approving Brain Cancer Drug with Duke TiesAugust 27th, 2024
  • FDA Approves Brain Cancer Drug with Duke Ties Giving Patients Hope
    FDA Approves Brain Cancer Drug with Duke Ties Giving Patients HopeAugust 26th, 2024
  • Join now to see all

Grant Support

  • Neuro-OncologyNational Cancer Institute2010–2012
  • SRC On Primary Tumors Of The CNSNational Institute Of Neurological Disorders And Stroke2009–2012
  • Ind, Regulatory And BioinformaticsNational Institute Of Neurological Disorders And Stroke2009–2012
  • Administrative CoreNational Institute Of Neurological Disorders And Stroke2009–2012
  • Brain Tumors - Immunological And Biological StudiesNational Cancer Institute2001–2012
  • NeurooncologyNational Cancer Institute2005–2009
  • Spore In Brain CancerNational Cancer Institute2004–2009
  • Core--Developmental Research ProgramNational Cancer Institute2004–2008
  • Core--Career Development ProgramNational Cancer Institute2004–2008
  • SRC On Primary And Metastatic Tumors Of The CNSNational Institute Of Neurological Disorders And Stroke1994–2008
  • Administration Support Core 5National Cancer Institute2004
  • Spore In Brain CancerNational Cancer Institute2002–2003
  • Rapid Development Of Glioma Targeting Reagents For TherapyNational Cancer Institute2002
  • Comprehensive Cancer Center Core Support GrantNational Cancer Institute2002
  • Clinical Trials With Solid Intracranial Tumors &Neoplastic MeningitisNational Institute Of Neurological Disorders And Stroke1999–2002
  • Core--Immunoincompetent Rodent &Biohazard FacilityNational Cancer Institute1999–2002
  • Core--General Laboratory And Animal SupportNational Institute Of Neurological Disorders And Stroke1994–2002
  • Brain Tumors--Immunological And Biological StudiesNational Cancer Institute1992–2000
  • Core--Cancer Center Isolation FacilityNational Cancer Institute1996–1998
  • Research Training In Neuro-OncologyNational Institute Of Neurological Disorders And Stroke1992–1996
  • Intrathecal Therapy Of Melanoma Neoplastic MeningitisNational Cancer Institute1991–1993
  • SRC On Malignant Human Gliomas And MedulloblastomasNational Institute Of Neurological Disorders And Stroke1989–1993
  • Increased Delivery Of Monoclonal Antibody RadioimmunoatherapyNational Institute Of Neurological Disorders And Stroke1989–1993
  • Brain Tumors: Immunological And Biological StudiesNational Cancer Institute1988–1991
  • Malignant Human Gliomas And MedulloblastomaNational Institute Of Neurological Disorders And Stroke1985–1988
  • Brain Tumors: Immunological And Biological StudiesNational Cancer Institute1985–1987
  • Conference On Brain Tumor Research And TherapyNational Institute Of Neurological Disorders And Stroke1985

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Darell Bigner, Dr. Darell Bigner, MD, Dr. D Bigner, Dr. Darell Doty Bigner